Abstract
The importance of the heart as a target for end-organ damage in hypertensive disease has long been recognized. This chapter describes the structural and functional cardiac and vascular alterations noted with sustained, pathological increases in systemic arterial blood pressure, as well as the clinical relevance of these alterations. Through mechanisms that include the hemodynamic effects of increased cardiac afterload, direct cellular influences, and activation of and interactions with various neurohumoral systems, systemic hypertension is able to affect phenotypic changes to the heart that most commonly include concentric left ventricular hypertrophy, and which result in altered diastolic and systolic myocardial function. Although typically subclinical, the cardiovascular alterations noted in response to chronic, pathological increases in systemic arterial blood pressure may increase the affected animal’s risk for life-threatening complications, particularly in patients with pre-existing heart disease or in those faced with additional hemodynamic stressors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Acierno MJ, Brown S, Coleman AE et al (2018) ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 32:1803–1822
Alyono D, Anderson RW, Parrish DG et al (1986) Alterations of myocardial blood flow associated with experimental canine left ventricular hypertrophy secondary to valvular aortic stenosis. Circ Res 58:47–57
Anderson LJ (1968) Arterial disease in canine interstitial nephritis. J Pathol Bacteriol 95:47–53
Anderson LJ, Fisher EW (1968) The blood pressure in canine interstitial nephritis. Res Vet Sci 9:304–313
Asemu G, O’Connell KA, Cox JW et al (2013) Enhanced resistance to permeability transition in interfibrillar cardiac mitochondria in dogs: effects of aging and long-term aldosterone infusion. Am J Physiol Heart Circ Physiol 304:H514–H528
Ayoub AM, Keddeas VW, Ali YA et al (2016) Subclinical LV dysfunction detection using speckle tracking echocardiography in hypertensive patients with preserved LV ejection fraction. Clin Med Insights Cardiol 10:85–90
Bai X, Wang Q (2010) Time constants of cardiac function and their calculations. Open Cardiovasc Med J 4:168–172
Bakris G, Sorrentino M (2018) Hypertension: a companion to Braunwald’s heart disease. Elsevier Saunders, Philadelphia
Ben-David J, Zipes DP, Ayers GM et al (1992) Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early after depolarizations after administration of BAY K 8644. J Am Coll Cardiol 20:1576–1584
Berk BC, Fujiwara K, Lehoux S (2007) ECM remodeling in hypertensive heart disease. J Clin Invest 117:568–575
Bissett SA, Drobatz KJ, McKnight A et al (2007) Prevalence, clinical features, and causes of epistaxis in dogs: 176 cases (1996–2001). J Am Vet Med Assoc 231:1843–1850
Bright R (1836) Tabular view of the morbid appearances occurring in one hundred cases in connection with albuminous urine. Guys Hosp Rep 1:380–400
Brown CA, Munday JS, Mathur S et al (2005) Hypertensive encephalopathy in cats with reduced renal function. Vet Pathol 42:642–649
Calhoun DA (2013) Hyperaldosteronism as a common cause of resistant hypertension. Annu Rev Med 64:233–247
Chahal NS, Lim TK, Jain P et al (2010) New insights into the relationship of left ventricular geometry and left ventricular mass with cardiac function: a population study of hypertensive subjects. Eur Heart J 31:588–594
Cheng CP, Igarashi Y, Little WC (1992) Mechanism of augmented rate of left ventricular filling during exercise. Circ Res 70:9–19
Chetboul V, Lefebvre HP, Pinhas C et al (2003) Spontaneous feline hypertension: clinical and echocardiographic abnormalities, and survival rate. J Vet Intern Med 17:89–95
Conroy M, Chang YM, Brodbelt D et al (2018) Survival after diagnosis of hypertension in cats attending primary care practice in the United Kingdom. J Vet Intern Med 32:1846–1855
Cooper G, Kent RL, Uboh CE et al (1985) Hemodynamic versus adrenergic control of cat right ventricular hypertrophy. J Clin Invest 75:1403–1414
Cortadellas O, del Palacio MJ, Bayon A et al (2006) Systemic hypertension in dogs with leishmaniasis: prevalence and clinical consequences. J Vet Intern Med 20:941–947
Crowley SD, Gurley SB, Herrera MJ et al (2006) Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103:17985–17990
Dahlof B, Devereux RB, Kjeldsen SE et al (2002) Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995–1003
Devereux RB, Roman MJ, de Simone G et al (1997) Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation 96:1416–1423
Devereux RB, Wachtell K, Gerdts E et al (2004) Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 292:2350–2356
Diez J, Querejeta R, Lopez B et al (2002) Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105:2512–2517
Dorn GW 2nd, Robbins J, Sugden PH (2003) Phenoty** hypertrophy: eschew obfuscation. Circ Res 92:1171–1175
Douglas PS, Tallant B (1991) Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension. J Am Coll Cardiol 17:530–536
Drazner MH (2011) The progression of hypertensive heart disease. Circulation 123:327–334
Dreslinski GR, Frohlich ED, Dunn FG et al (1981) Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index. Am J Cardiol 47:1087–1090
du Cailar G, Pasquie JL, Ribstein J et al (2000) Left ventricular adaptation to hypertension and plasma renin activity. J Hum Hypertens 14:181–188
Elliott J, Barber PJ, Syme HM et al (2001) Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract 42:122–129
Esposito G, Rapacciuolo A, Naga Prasad SV et al (2002) Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105:85–92
Feola M, Boffano GM, Procopio M et al (1998) Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients. G Ital Cardiol 28:38–44
Frey N, Katus HA, Olson EN et al (2004) Hypertrophy of the heart: a new therapeutic target? Circulation 109:1580–1589
Frohlich ED, Apstein C, Chobanian AV et al (1992) Medical progress—the heart in hypertension. N Engl J Med 327:998–1008
Ganau A, Devereux RB, Roman MJ et al (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19:1550–1558
Geisterfer AA, Peach MJ, Owens GK (1988) Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62:749–756
Ghali JK, Liao Y, Cooper RS (1998) Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 31:1635–1640
Giannattasio C, Laurent S (2014) Central blood pressure. Manual of hypertension of the European society of hypertension, 2nd edn. CRC Press, London, pp 257–268
Gilbert JC, Glantz SA (1989) Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circ Res 64:827–852
Glennon PE, Sugden PH, Poole-Wilson PA (1995) Cellular mechanisms of cardiac hypertrophy. Br Heart J 73:496–499
Gouni V, Papageorgiou S, Debeaupuits J et al (2018) Aortic dissecting aneurysm associated with systemic arterial hypertension in a cat. Schweiz Arch Tierheilkd 160:320–324
Greenwald SE (2007) Ageing of the conduit arteries. J Pathol 211:157–172
Grossman W, Jones D, McLaurin LP (1975) Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56:56–64
Gull WW, Sutton HG (1872) On the pathology of the morbid state commonly called chronic Bright’s disease with contracted kidney (“arterio-capillary fibrosis.”). Med Chir Trans 55:273–330.1
Haidet GC, Wennberg PW, Finkelstein SM et al (1996) Effects of aging per se on arterial stiffness: systemic and regional compliance in beagles. Am Heart J 132:319–327
Hayashida W, Donckier J, Van Mechelen H et al (1997) Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade. Cardiovasc Res 33:54–62
Henik RA, Stepien RL, Bortnowski HB (2004) Spectrum of M-mode echocardiographic abnormalities in 75 cats with systemic hypertension. J Am Anim Hosp Assoc 40:359–363
Hill JA, Karimi M, Kutschke W et al (2000) Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 101:2863–2869
Janeway TIC (1913) A clinical study of hypertensive cardiovascular disease. Arch Intern Med 12:755–798
Jensen J, Henik RA, Brownfield M et al (1997) Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Am J Vet Res 58:535–540
Jepson RE, Syme HM, Elliott J (2014) Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate. J Vet Intern Med 28:144–153
Jeremy RW, Fletcher PJ, Thompson J (1989) Coronary pressure-flow relations in hypertensive left ventricular hypertrophy. Comparison of intact autoregulation with physiological and pharmacological vasodilation in the dog. Circ Res 65:224–236
Keene BW, Smith FWK, Tilley LP et al (2015) Rapid interpretation of heart and lung sounds: a guide to cardiac and respiratory auscultation in dogs and cats, 3rd edn. Elsevier Saunders, St. Louis, MO
Kizer JR, Arnett DK, Bella JN et al (2004) Differences in left ventricular structure between black and white hypertensive adults: the hypertension genetic epidemiology network study. Hypertension 43:1182–1188
Kjeldsen SE, Dahlof B, Devereux RB et al (2002) Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 288:1491–1498
Kleiman RB, Houser SR (1988) Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. Am J Phys 255:H1434–H1442
Kleiman RB, Houser SR (1989) Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Phys 256:H1450–H1461
Klingbeil AU, Schneider M, Martus P et al (2003) A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 115:41–46
Kohnken R, Scansen BA, Premanandan C (2017) Vasa Vasorum Arteriopathy: relationship with systemic arterial hypertension and other vascular lesions in cats. Vet Pathol 54:475–483
Koide M, Nagatsu M, Zile MR et al (1997) Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine. Circulation 95:1601–1610
Kollias A, Lagou S, Zeniodi ME et al (2016) Association of central versus brachial blood pressure with target-organ damage: systematic review and meta-analysis. Hypertension 67:183–190
Krishnamoorthy A, Brown T, Ayers CR et al (2011) Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up. Am J Cardiol 108:997–1001
Krumholz HM, Larson M, Levy D (1993) Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 72:310–313
Lauer MS, Anderson KM, Levy D (1991) Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 18:1287–1294
Lazzeroni D, Rimoldi O, Camici PG (2016) From left ventricular hypertrophy to dysfunction and failure. Circ J 80:555–564
Lesser M, Fox PR, Bond BR (1992) Assessment of hypertension in 40 cats with left-ventricular hypertrophy by Doppler-Shift sphygmomanometry. J Small Anim Pract 33:55–58
Levy D, Anderson KM, Savage DD et al (1988) Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 108:7–13
Levy D, Garrison RJ, Savage DD et al (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566
Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913
Little WC (1992) Enhanced load dependence of relaxation in heart failure. Clinical implications. Circulation 85:2326–2328
Littman MP (1994) Spontaneous systemic hypertension in 24 cats. J Vet Intern Med 8:79–86
Littman MP, Robertson JL, Bovee KC (1988) Spontaneous systemic hypertension in dogs: five cases (1981–1983). J Am Vet Med Assoc 193:486–494
Maggio F, DeFrancesco TC, Atkins CE et al (2000) Ocular lesions associated with systemic hypertension in cats: 69 cases (1985–1998). J Am Vet Med Assoc 217:695–702
Maier LS, Bers DM (2002) Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J Mol Cell Cardiol 34:919–939
Mathew J, Sleight P, Lonn E et al (2001) Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 104:1615–1621
McLenachan JM, Dargie HJ (1990) Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens 3:735–740
Meerson FZ (1961) On the mechanism of compensatory hyperfunction and insufficiency of the heart. Cor Vasa 3:161–177
Milliez P, Girerd X, Plouin PF et al (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243–1248
Misbach C, Gouni V, Tissier R et al (2011) Echocardiographic and tissue Doppler imaging alterations associated with spontaneous canine systemic hypertension. J Vet Intern Med 25:1025–1035
Molkentin JD, Lu JR, Antos CL et al (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215–228
Moon ML, Keene BW, Lessard P et al (1993) Age-related-changes in the feline cardiac Silhouette. Vet Radiol Ultrasound 34:315–320
Morioka S, Simon G (1981) Echocardiographic evidence for early left-ventricular hypertrophy in renal hypertensive dogs. Am J Cardiol 47:478–478
Muiesan ML, Salvetti M, Monteduro C et al (2004) Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 43:731–738
Munagala VK, Hart CY, Burnett JC Jr et al (2005) Ventricular structure and function in aged dogs with renal hypertension: a model of experimental diastolic heart failure. Circulation 111:1128–1135
Muscholl MW, Schunkert H, Muders F et al (1998) Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J 135:58–66
Nelson L, Reidesel E, Ware WA et al (2002) Echocardiographic and radiographic changes associated with systemic hypertension in cats. J Vet Intern Med 16:418–425
Nichols WW, Pepine CJ (1982) Left ventricular afterload and aortic input impedance: implications of pulsatile blood flow. Prog Cardiovasc Dis 24:293–306
Nicolle AP, Carlos Sampedrano C, Fontaine JJ et al (2005) Longitudinal left ventricular myocardial dysfunction assessed by 2D colour tissue Doppler imaging in a dog with systemic hypertension and severe arteriosclerosis. J Vet Med A Physiol Pathol Clin Med 52:83–87
Ohsato K, Shimizu M, Sugihara N et al (1992) Histopathological factors related to diastolic function in myocardial hypertrophy. Jpn Circ J 56:325–333
Okin PM, Devereux RB, Jern S et al (2004) Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 292:2343–2349
Opie LH, Gersh BJ (2009) Drugs for the heart, 7th edn. Saunders/Elsevier, Philadelphia
Paige CF, Abbott JA, Elvinger F et al (2009) Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc 234:1398–1403
Patel PD, Arora RR (2008) Pathophysiology, diagnosis, and management of aortic dissection. Ther Adv Cardiovasc Dis 2:439–468
Payne JR, Brodbelt DC, Luis FV (2015) Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study). J Vet Cardiol 17(Suppl 1):S244–S257
Pewsner D, Juni P, Egger M et al (2007) Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ 335:711
Pirie HM, Mackey JL, Fisher EW (1965) The relationship between renal disease and arterial lesions in the dog. Ann N Y Acad Sci 127:861–873
Pitt B, Reichek N, Willenbrock R et al (2003) Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108:1831–1838
Rame JE, Ramilo M, Spencer N et al (2004) Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. Am J Cardiol 93:234–237
Renna NF, Heras NDL, Miatello RM (2013) Pathophysiology of vascular remodeling in hypertension. Int J Hypertens 2013:808353
Rials SJ, Wu Y, Ford N et al (1995) Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation 91:426–430
Rials SJ, Wu Y, Pauletto FJ et al (1996) Effect of an intravenous angiotensin-converting enzyme inhibitor on the electrophysiologic features of normal and hypertrophied feline ventricles. Am Heart J 132:989–994
Rishniw M, Thomas WP (2002) Dynamic right ventricular outflow obstruction: a new cause of systolic murmurs in cats. J Vet Intern Med 16:547–552
Romito G, Guglielmini C, Mazzarella MO et al (2018) Diagnostic and prognostic utility of surface electrocardiography in cats with left ventricular hypertrophy. J Vet Cardiol 20:364–375
Rouleau JR, Simard D, Blouin A et al (2002) Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy. Basic Res Cardiol 97:384–391
Sadoshima J, Izumo S (1993) Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J 12:1681–1692
Sadoshima J, Jahn L, Takahashi T et al (1992) Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem 267:10551–10560
Sampedrano CC, Chetboul V, Gouni V et al (2006) Systolic and diastolic myocardial dysfunction in cats with hypertrophic cardiomyopathy or systemic hypertension. J Vet Intern Med 20:1106–1115
Sano M, Schneider MD (2002) Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload. Circulation 105:8–10
Sansom J, Rogers K, Wood JL (2004) Blood pressure assessment in healthy cats and cats with hypertensive retinopathy. Am J Vet Res 65:245–252
Sato A, Takane H, Saruta T (2001) High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients. Hypertens Res 24:99–104
Schumann CL, Jaeger NR, Kramer CM (2019) Recent advances in imaging of hypertensive heart disease. Curr Hypertens Rep 21:3
Scollan K, Sisson D (2014) Multi-detector computed tomography of an aortic dissection in a cat. J Vet Cardiol 16:67–72
Shechter JA, O’Connor KM, Friehling TD et al (1989) Electrophysiologic effects of left ventricular hypertrophy in the intact cat. Am J Hypertens 2:81–85
Snyder PS, Sadek D, Jones GL (2001) Effect of amlodipine on echocardiographic variables in cats with systemic hypertension. J Vet Intern Med 15:52–56
Sparks MA, Parsons KK, Stegbauer J et al (2011) Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension. Hypertension 57:577–585
Stamler J, Stamler R, Neaton JD (1993) Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 153:598–615
Stanley WC, Cox JW, Asemu G et al (2013) Evaluation of docosahexaenoic acid in a dog model of hypertension induced left ventricular hypertrophy. J Cardiovasc Transl Res 6:1000–1010
Sugawara J, Hayashi K, Yokoi T et al (2008) Age-associated elongation of the ascending aorta in adults. JACC-Cardiovasc Imaging 1:739–748
Syme HM, Barber PJ, Markwell PJ et al (2002) Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation. J Am Vet Med Assoc 220:1799–1804
Tanabe A, Naruse M, Naruse K et al (1997) Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 20:85–90
Ten Eick RE, Zhang K, Harvey RD et al (1993) Enhanced functional expression of transient outward current in hypertrophied feline myocytes. Cardiovasc Drugs Ther 7(Suppl 3):611–619
Tilley LP (1992) Essentials of canine and feline electrocardiography: interpretation and treatment, 3rd edn. Lea & Febiger, Philadelphia
Tomanek RJ, Searls JC, Lachenbruch PA (1982) Quantitative changes in the capillary bed during develo**, peak, and stabilized cardiac hypertrophy in the spontaneously hypertensive rat. Circ Res 51:295–304
Tomanek RJ, Wessel TJ, Harrison DG (1991) Capillary growth and geometry during long-term hypertension and myocardial hypertrophy in dogs. Am J Phys 261:H1011–H1018
Vakili BA, Okin PM, Devereux RB (2001) Prognostic implications of left ventricular hypertrophy. Am Heart J 141:334–341
Valtonen MH, Oksanen A (1972) Cardiovascular disease and nephritis in dogs. J Small Anim Pract 13:687–697
Velagaleti RS, Gona P, Levy D et al (2008) Relations of biomarkers representing distinct biological pathways to left ventricular geometry. Circulation 118:2252–2258, 2255p, following 2258
Verdecchia P, Schillaci G, Borgioni C et al (1995) Adverse prognostic-significance of concentric remodeling of the left-ventricle in hypertensive patients with normal left-ventricular mass. J Am Coll Cardiol 25:871–878
Wachtell K, Bella JN, Rokkedal J et al (2002) Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) study. Circulation 105:1071–1076
Waldrop JE, Stoneham AE, Tidwell AS et al (2003) Aortic dissection associated with aortic aneurysms and posterior paresis in a dog. J Vet Intern Med 17:223–229
Wallner M, Eaton DM, Berretta RM et al (2017) A feline HFpEF model with pulmonary hypertension and compromised pulmonary function. Sci Rep 7:16587
Weiser MG, Spangler WL, Gribble DH (1977) Blood pressure measurement in the dog. J Am Vet Med Assoc 171:364–368
Wey AC, Atkins CE (2000) Aortic dissection and congestive heart failure associated with systemic hypertension in a cat. J Vet Intern Med 14:208–213
Whitney JC (1976) Some aspects of pathogenesis of canine arteriosclerosis. J Small Anim Pract 17:87–97
Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Coleman, A.E., Brown, S.A. (2020). Hypertension and the Heart and Vasculature. In: Elliott, J., Syme, H., Jepson, R. (eds) Hypertension in the Dog and Cat. Springer, Cham. https://doi.org/10.1007/978-3-030-33020-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-33020-0_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33019-4
Online ISBN: 978-3-030-33020-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)